OrthoPediatrics’ scoliosis system gains FDA clearance

The FDA granted OrthoPediatrics 510(k) clearance to expand its Response Scoliosis system to include neuromuscular implants on March 31.

Advertisement

Three insights:

1. The Response NeuroMuscular system is intended for the treatment of neuromuscular scoliosis in pediatric patients.

2. The device will feature a full set of implants and instruments to facilitate insertion and help treat severe hyperlordosis.

3. A team of pediatric orthopedic surgeons is building upon OrthoPediatrics’ Response Spine system to develop the technology.

More articles on devices:
6 industry layoffs, furloughs for physician leaders to know
Dr. Neal ElAttrache defends orthopedic surgeries performed during COVID-19 crisis
‘The patients are deferred; they’re not going away,’ says Life Spine CEO on coronavirus

At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.

Register to Attend Webinar

160 ambulatory leaders just ranked the EHR as the single system most overdue for AI reinvention

Tuesday, August 11
12:00 PM - 1:00 PM CDT

Presenter: Gautam Shah, MBA, FACHDM, NextGen Healthcare

Advertisement

Next Up in Spinal Tech

Advertisement

Comments are closed.